CTNM vs NSC · $429.6M cap vs P/E 18, rev $6.46B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
CTNM currently screens at market cap $429.6M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the CTNM and NSC stock pages for the full models.
Not investment advice.